Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06003192 · ClinicalTrials.gov registry record · NA

Screen Smart: Using Digital Health to Improve HIV Screening and Prevention

A NA study of HIV Infections, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
63,000
Enrollment target
4
Study locations

NCT06003192: Recruiting NA study of HIV Infections, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT06003192 is a NA study of HIV Infections that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 63,000 participants, above the 330-participant average among 542 other HIV Infections trials with a reported enrollment target (18991% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06003192, a NA study of HIV Infections, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
63,000 participants
Enrollment target
4
Study locations

Study Summary

The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question\[s\] it aims to answer are: 1. What is the uptake, reach and effectiveness of universally offered, opt-out HIV screening across pediatric EDs after implementing an adapted version of a tablet-based screening process? 2. What is the successful linkage to comprehensive HIV pre-exposure prophylaxis (PrEP) care using a novel, digital health platform? Participants will 1. Complete the previously developed and validated computerized sexual health screen (cSHS) containing questions regarding their personal sexual health history 2. Have the opportunity to opt-out of clinician-ordered HIV testing 3. Patients meeting CDC criteria for HIV PrEP will be given the opportunity to enroll in the digital health PrEP linkage platform and followed for 3 months after enrollment.

Primary Outcome

We will employ interrupted time series analyses to compare these rates between baseline (usual care) and upon implementation of universally offered, opt-out HIV screening strategy.

Conditions Studied

Interventions

  • OTHER Universal Opt-out HIV Screening

Study Locations (4)

Ohio

  • Nationwide Children's Hospital - Columbus

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Utah

  • University of Utah - Salt Lake City

Wisconsin

  • Children's Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 63,000 participants
Start Date 2024-12-16
Est. Completion 2028-03-15
Phase NA

What NCT06003192 shows while recruiting

NCT06003192 is an interventional study that assigns participants to a tested intervention. Its 63,000 participants enrollment target places it among the larger protocols in the corpus, above the 330-participant average among 542 other HIV Infections trials with a reported enrollment target (18991% higher).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Universal Opt-out HIV Screening is the first listed.

NCT06003192 reports a single indexed study location in Ohio, Pennsylvania, Utah.

Frequently Asked Questions

What is clinical trial NCT06003192 about?

NCT06003192 is a clinical study titled "Screen Smart: Using Digital Health to Improve HIV Screening and Prevention". The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question\[s\] it aims to answer are: 1. What is the upt...

What is the current status of trial NCT06003192?

This trial is currently recruiting. It is a NA study. The enrollment target is 63,000 participants. The study started on 2024-12-16. Estimated completion is 2028-03-15.

What conditions does trial NCT06003192 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT06003192?

The interventions under investigation include: Universal Opt-out HIV Screening (OTHER).

Who is sponsoring clinical trial NCT06003192?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06003192 being conducted?

This trial has 4 study locations across Ohio, Pennsylvania, Utah, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06003192's enrollment target sits among peer trials

63,000 1st of 542 higher than 542 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05128006 · 63,200 participants

    Direct-to-patient Teledermatology and Computer-assisted Diagnosis

  • NCT05723614 · 61,770 participants · NA

    TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

  • NCT04473833 · 65,000 participants · NA

    Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

  • NCT03752840 · 60,200 participants · NA

    Village-Integrated Eye Worker Trial II

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06003192, the US trial registry maintained by the National Library of Medicine. NCT06003192 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.